<img alt="" height="1" width="1" />Phase 2 Trial of LX4211 Demonstrates Significant and Rapid Improvements in ...PR Newswire (press release)Lexicon currently has five drug candidates in development for autoimmune disease, carcinoid syndrome, diabetes, glaucoma and irritable bowel syndrome, ...<nobr>and more »</nobr> |